Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The company's portfolio includes a range of sequencing systems, such as the NovaSeq, NextSeq, and MiSeq series, which enable high-throughput genomic analysis. Illumina's technology is foundational to the field of precision medicine, supporting applications in oncology, reproductive health, and genetic disease research. Beyond hardware, the company provides integrated software solutions and consumables that streamline the genomic workflow from sample preparation to data analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alumina.